A research and training consortium with a focus on combating neurodegenerative disorders is recruiting 23 PhD students for 3-year fellowships. Known as SyMBaD (Synapses: from Molecules to Brain and Diseases), the consortium comprises six neuroscience institutes and six technology and pharmaceutical firms from across Europe, and has won €5 million (US$7 million) in European Union funding through the Marie Curie Initial Training Network. Fellows will receive an annual salary and allowances package of up to €48,600 and will train with and move between the network's members to boost collaborative efforts. Students from any country may apply but Europeans cannot study in their home country.